Vimarsana
Biggest News Aggregation in the World

Page 14 - Two Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Two Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Two Phase Today - Breaking & Trending Today

Investegate |RedHill Biopharma Announcements | RedHill Biopharma: Concerning Clarithromycin Rx Rates for H. pylori - Vimarsana News

Investegate |RedHill Biopharma Announcements | RedHill Biopharma: Concerning Clarithromycin Rx Rates for H. pylori

Investegate announcements from RedHill Biopharma, Concerning Clarithromycin Rx Rates for H. pylori

AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021 - Vimarsana News

AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021 - Vimarsana News

AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021

ABBVie today announced the presentation of new data on RINVOQ ® SKYRIZI ® and HUMIRA ® across multiple rheumatic diseases at the American College of Rheumatology's annual meeting to be held virtually Nov. 3-9 . A total of 38 abstracts, including two oral presentations and one plenary session presentation, will be presented from a broad range of studies in rheumatoid arthritis, psoriatic arthritis and ankylosing ...

AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021 - Vimarsana News

AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the presentation of new data on RINVOQ® (upadacitinib), SKYRIZI® (risankizumab) and HUMIRA® (adalimumab)...

RedHill Biopharma Presents New Talicia® and Movantik® Data Analyses at ACG 2021 - Vimarsana News

RedHill Biopharma Presents New Talicia® and Movantik® Data Analyses at ACG 2021

/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the presentation of...